© 2022 MJH Life Sciences and Contemporary OB/GYN. All rights reserved.
July 12, 2022
Steven J. Chmura, MD, PhD, discussed recent findings from the phase 2R/3 NRG-BR002 trial in patients with newly diagnosed oligometastatic breast cancer.
February 18, 2022
Cancer misinformation may be more prevalent among residents in rural vs urban areas, study finds.
December 01, 2021
Olaparib, which was granted priority review by the FDA, has been shown to improve invasive disease-free survival for patients with BRCA-mutated HER2-negative high-risk early breast cancer.
November 24, 2021
Attention needs to be paid to the psychosocial needs of patients, especially those with poor health-related quality of life, who have little support, or are single mothers.